Veterinary Data for Equipment Manufacturers

The problem

Selling diagnostic or surgical equipment to vet practices means knowing which practices have the volume and specialty focus to actually need your products. ZoomInfo lists 'veterinary services' as a single category.

Equipment deals are five and six figures with committee-length sales cycles. One qualified referral hospital is worth more than a hundred one-doctor clinics that will never buy a $60,000 imaging unit. A flat list treats them identically.

How Vettica solves this

Vettica segments practices by specialty type and size. Target dermatology practices for skin imaging equipment. Reach emergency and referral hospitals for advanced monitoring. Filter by DVM headcount so your capital equipment reps only see practices with the caseload to justify the purchase. Every contact includes verified emails and direct phone numbers for decision-makers, not generic info@ addresses.

Ownership determines the buying process

An independent practice owner can approve an equipment purchase in a week. A corporate-owned location routes it through a regional procurement process that may standardize on your competitor. Our ownership flags tell your reps which conversation they're walking into, and for corporate groups, the flag identifies the parent so your enterprise team can work the account at the right level.

Timing signals worth ordering

With technology detection, records show which diagnostic ecosystem a practice already committed to: IDEXX, Zoetis, or Heska equipment each imply different upgrade paths and consumables contracts. Practices posting jobs for surgical or imaging technicians are staffing up for capacity, which often precedes equipment spend. These signals turn a cold list into a call plan.

How to get started

Tell us the specialty profile and deal size your equipment sells into, and the territories your reps cover. We'll quote a list scoped to practices that fit, with a record count estimate up front. Most equipment vendors start with one product line in one region and expand after the first quarter's pipeline proves out.